PDK4
Basic information
Region (hg38): 7:95583499-95596516
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (49 variants)
- not_provided (3 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDK4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002612.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 49 | 51 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 50 | 1 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PDK4 | protein_coding | protein_coding | ENST00000005178 | 11 | 12993 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 9.14e-12 | 0.149 | 125666 | 0 | 82 | 125748 | 0.000326 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.351 | 208 | 223 | 0.934 | 0.0000112 | 2677 |
| Missense in Polyphen | 97 | 102.38 | 0.94747 | 1176 | ||
| Synonymous | -1.27 | 92 | 77.8 | 1.18 | 0.00000367 | 781 |
| Loss of Function | 0.677 | 19 | 22.5 | 0.846 | 0.00000117 | 273 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000711 | 0.000703 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000441 | 0.000381 |
| Finnish | 0.000185 | 0.000185 |
| European (Non-Finnish) | 0.000390 | 0.000387 |
| Middle Eastern | 0.000441 | 0.000381 |
| South Asian | 0.000329 | 0.000327 |
| Other | 0.000498 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Kinase that plays a key role in regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism in response to prolonged fasting and starvation. Plays an important role in maintaining normal blood glucose levels under starvation, and is involved in the insulin signaling cascade. Via its regulation of pyruvate dehydrogenase activity, plays an important role in maintaining normal blood pH and in preventing the accumulation of ketone bodies under starvation. In the fed state, mediates cellular responses to glucose levels and to a high-fat diet. Regulates both fatty acid oxidation and de novo fatty acid biosynthesis. Plays a role in the generation of reactive oxygen species. Protects detached epithelial cells against anoikis. Plays a role in cell proliferation via its role in regulating carbohydrate and fatty acid metabolism. {ECO:0000269|PubMed:15955060, ECO:0000269|PubMed:18658136, ECO:0000269|PubMed:21816445, ECO:0000269|PubMed:21852536}.;
- Pathway
- Estrogen Receptor Pathway;Nuclear Receptors Meta-Pathway;Amino Acid metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors
(Consensus)
Recessive Scores
- pRec
- 0.354
Intolerance Scores
- loftool
- 0.801
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.92
Haploinsufficiency Scores
- pHI
- 0.215
- hipred
- N
- hipred_score
- 0.443
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.961
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdk4
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; skeleton phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- glucose metabolic process;protein phosphorylation;regulation of pH;insulin receptor signaling pathway;cellular response to starvation;regulation of acetyl-CoA biosynthetic process from pyruvate;regulation of cellular ketone metabolic process;regulation of glucose metabolic process;regulation of fatty acid biosynthetic process;glucose homeostasis;response to starvation;regulation of bone resorption;regulation of fatty acid oxidation;cellular response to fatty acid;reactive oxygen species metabolic process;negative regulation of anoikis
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- protein kinase activity;pyruvate dehydrogenase (acetyl-transferring) kinase activity;ATP binding